Masimo Corporation (MASI)
Bid | 141.19 |
Market Cap | 8.21B |
Revenue (ttm) | 2.09B |
Net Income (ttm) | -304.9M |
EPS (ttm) | -5.72 |
PE Ratio (ttm) | -26.59 |
Forward PE | 25.83 |
Analyst | Buy |
Ask | 154.35 |
Volume | 377,507 |
Avg. Volume (20D) | 592,147 |
Open | 151.68 |
Previous Close | 151.68 |
Day's Range | 150.72 - 153.78 |
52-Week Range | 101.61 - 194.88 |
Beta | 1.28 |
About MASI
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products t...
Analyst Forecast
According to 6 analyst ratings, the average rating for MASI stock is "Buy." The 12-month stock price forecast is $194, which is an increase of 27.54% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription

2 weeks ago · businesswire.com
Masimo to Present in the 24th Annual Needham Virtual Healthcare ConferenceIRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the 24th Annual Needham Virtual Healthcare Conference on Wednesday, April 9, 2025 at 2:15...